Kalkat R K, Cartmill R S V
Good Hope Hospital, Heart of England NHS Foundation Trust, Birmingham, UK.
J Obstet Gynaecol. 2011;31(2):152-5. doi: 10.3109/01443615.2010.538772.
The use of NovaSure under local anaesthesia (LA) has been described as part of efficacy trials, but its use in an outpatient setting has not previously been explored. This prospective study was conducted to determine feasibility and efficacy of NovaSure in the outpatient setting under LA. The study included all women with menorrhagia unresponsive to medical management and were agreeable for treatment under LA (n = 50). The mean duration of procedure was 100 s. A total of 47 (94%) patients were discharged home the same day. Simple analgesics controlled postoperative pain in 44 (88%) patients. Seven (14%) patients gave preference for general anaesthesia for future treatment. The mean pain scores at 30, 60 and 90 min were 4.18, 4.38 and 3.85, respectively on the visual analogue scale. At follow-up, the improvement in menstrual symptoms was seen in 47 (94%) and the satisfaction rate was 43 (86%) and 47 (94%) at 4 and 6 months, respectively.
在局部麻醉（LA）下使用NovaSure已被描述为疗效试验的一部分，但此前尚未探讨其在门诊环境中的使用情况。本前瞻性研究旨在确定NovaSure在局部麻醉下门诊环境中的可行性和疗效。该研究纳入了所有对药物治疗无效且同意在局部麻醉下接受治疗的月经过多女性（n = 50）。手术平均持续时间为100秒。共有47名（94%）患者在同一天出院回家。简单镇痛药控制了44名（88%）患者的术后疼痛。7名（14%）患者更倾向于在未来治疗时选择全身麻醉。在视觉模拟量表上，30、60和90分钟时的平均疼痛评分分别为4.18、4.38和3.85。随访时，47名（94%）患者的月经症状有所改善，4个月和6个月时的满意率分别为43名（86%）和47名（94%）。
